Posters/presentations issued for conferences

The following documents are available in PDF format.

CRS (Controlled Release Society) @Blogna, July 8-12/2024

  • ・Innovation Showcase: Hyaluronic Acid Nanogel (Sonanos™) (Yoshiyuki NAKAGAWA)

    PDF Download

  • ・Sustained release of poorly water-soluble peptide facilitated by cholesterol-modified hyaluronic acid nanogel
    　salt-responsive gelation (Shogo ASO)

    PDF Download

  • ・Industry Tech Forum: Innovative Pharma Excipient Hyaluronic Acid Nanogel (Sonanos™) for Solubilization,
    　Sustained Release and Lymph Node Delivery (Yoshiyuki NAKAGAWA)

    PDF Download

PBP(14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology) @Vienna, Mar 18-21/2024

  • ・Cholesterol-Modified Hyaluronic Acid Nanogels for Solubility Enhancement and Sustained Release (Yoshiyuki NAKAGAWA)

    PDF Download

  • ・Hyaluronic acid-based NPs Augment infused T cell therapy (Takero KUROSAWA)

    PDF Download

AAPS(American Association of Pharmaceutical Scientists) @Orland, Oct 22-25/2023

  • ・Long-Acting Drug Delivery System for Subcutaneous, Intravitreal, and Intra-articular Administration
    　using Hyaluronic Acid-Based In Situ Gelling Nanosuspension Formulation of Water-Insoluble Drugs (Takashi NAKAI)

    PDF Download

  • ・Co-micelle Technology by Hyaluronic Acid (HA) Nanogel (trade name Sonanos™) Solubilize
    　as much of a Poorly Water-Soluble Drug as Possible with as Little as Possible (Kohei YABUUCHI)

    PDF Download

  • ・Hyaluronic Acid Nanogel Cancer Vaccine: Powerful and Versatile Priming Tool for Combinational T Cell Therapy
    　(Takashi NAKAI)

    PDF Download

  • ・Hyaluronic Nanogel: Facile Fabrication for Solubilization, SR and Vaccine Applications (Takero KUROSAWA)

    PDF Download

4th European Conference on pharmaceutics @Marseille, Mar 20-21/2023

  • ・Hyaluronic Acid Nanogel for Protein Delivery System and Vaccine Application (Shogo ASO)

    PDF Download

  • ・Unique Characteristics of the New Additive HA nanogel (Daichi TANAKA)

    PDF Download

TIDES ASIA @Kyoto, Mar 7-9/2023

  • ・Improvement the solubility of cyclic peptide (Kohei YABUUCHI)

    PDF Download

AAPS(American Association of Pharmaceutical Scientists) @Boston, Oct 16-19/2022

  • ・Nanosuspension Formulation of Water-Insoluble Cyclic Peptides (Takashi NAKAI)

    PDF Download

  • ・HA Nanogel / Spike Protein Complex Induces One-year Persistent Antibody Production (Toru KATSHUMATA)

    PDF Download

  • ・How to Improve in Solubility of Water-Insoluble Cyclic Peptide with HA nanogel (Kohei YABUUCHI)

    PDF Download
TOP

Cookie Policy

We use Access Data (Data on devices that visitors to this website use) and Cookie (text files containing small amounts of information which will be downloaded to your device upon your visit to a website) of visitors to this website.
With regards to the handling of such data, we follow Asahi Kasei’s Cookie policy except for the followings. For clarity, “this website” in the aforementioned Cookie policy, shall include www.ceolus.com.

We use Access Data and Cookie obtained through this website for following purposes;
- For the purpose that is specified in 1.(1) Purpose of use in Asahi Kasei’s privacy policy.
- For the purpose of providing you with information concerning our products or business by direct mail or e-mail.
Such information may be provided to you by following Asahi Kasei group companies (hereunder “Asahi Kasei Group Companies”):

Analytical tool

This website uses Google Analytics, an analytical tool that is provided by Google Inc. Please go to Google Inc.’s website for their privacy policy and Cookie policy.

Outsourcing Contractor

With regards to Access Data and Cookie of visitors to this website that was provided upon user registration, Access Data and Cookie, moving forward to smoothly run our operations, Asahi Kasei and Asahi Kasei group companies may entrust a part of our operations to third party contractors and provide such third party contractors with Access Data and Cookie to the extent that is required. In such cases, Asahi Kasei and Asahi Kasei group companies shall adopt third party contractors that are appropriate to handle Access Data and Cookie, and set appropriate controls in place such as having agreement on handling of Access Data and Cookie in place with them.

If you have any questions or complaints for the handling of Personal Data, etc, and terms and conditions of this website, please contact followings:

Healthcare Materials Division
Asahi Kasei Corporation